Home » Topics » Patents, BioWorld Science

Patents, BioWorld Science
RSS

Novel anti-HCV agents targeting NS3-NS4A protease claimed by Enanta

Oct. 6, 2004

Two novel series of chemokine CCR2 antagonists identified at BMS

Oct. 6, 2004

BMS scientists present two novel series of factor VIIa inhibitors

Oct. 6, 2004

Three series of COX-2 inhibitors designed at Almirall Prodesfarma

Oct. 6, 2004

French team identifies new G-quadruplex-binding telomerase inhibitors

Oct. 5, 2004

New antiangiogenic kinase inhibitors discovered at Cellular Genomics

Oct. 5, 2004

Non-hemolytic indolicidin-based antibiotics identified by Indian researchers

Oct. 5, 2004

Optically active calcium antagonists and their use in hypertension and other disorders

Oct. 5, 2004

New nAChR ligands and their use described by Aventis and Targacept

Oct. 5, 2004

Novel beta3-adrenoceptor agonists covered by Kissei patent

Oct. 5, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...